日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

PROTAC 介导的 BCL-xL 和 BCL-2 双重降解是小细胞肺癌的一种高效治疗策略

Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Frederic J Kaye, Guangrong Zheng, Daohong Zhou

PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer

PROTAC 介导的 BCL-xL 和 BCL-2 双重降解是小细胞肺癌的一种高效治疗策略

Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Frederic J Kaye, Guangrong Zheng, Daohong Zhou

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

TYMS 在 Ink4a/Arf 无效背景下促进基因组不稳定性和肿瘤进展

Maria V Guijarro #, Akbar Nawab #, Peter Dib, Sandra Burkett, Xiaoping Luo, Michael Feely, Elham Nasri, Robert P Seifert, Frederic J Kaye, Maria Zajac-Kaye

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

将 BCL-XL 和 MCL-1 与 DT2216 和 AZD8055 共同靶向可协同抑制小细胞肺癌生长,且不会在小鼠中引起靶向毒性

Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J Kaye, Daohong Zhou

Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival

胸苷酸合酶加速 Men1 介导的胰腺肿瘤进展并降低生存率

Vinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, Benjamin Meyer, Sandra Burkett, Akbar Nawab, Michael W Dougherty, Christian Jobin, Iqbal Mahmud, Timothy J Garrett, Michael Feely, Kyoung Bun Lee, Frederic J Kaye, Maria V Guijarro, Maria Zajac-Kaye

Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival

溶瘤病毒疗法治疗小细胞肺癌可诱导免疫浸润并延长生存期

Patrick Kellish ,Daniil Shabashvili ,Masmudur M Rahman ,Akbar Nawab ,Maria V Guijarro ,Min Zhang ,Chunxia Cao ,Nissin Moussatche ,Theresa Boyle ,Scott Antonia ,Mary Reinhard ,Connor Hartzell ,Michael Jantz ,Hiren J Mehta ,Grant McFadden ,Frederic J Kaye ,Maria Zajac-Kaye

MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma

用于测试腺样囊性癌治疗药物的 MYB 激活模型

Yue Jiang, Ruli Gao, Chunxia Cao, Lauren Forbes, Jianping Li, Shelby Freeberg, Kristianna M Fredenburg, Jeb M Justice, Natalie L Silver, Lizi Wu, Sushama Varma, Robert West, Jonathan D Licht, Maria Zajac-Kaye, Alex Kentsis, Frederic J Kaye

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition

CDK4/6 抑制可稳定 p16 基因缺失的非小细胞肺癌患者的病情,并与 mTOR 抑制产生协同作用

Priya K Gopalan, Andres Gordillo Villegas, Chunxia Cao, Mary Pinder-Schenck, Alberto Chiappori, Wei Hou, Maria Zajac-Kaye, Alison M Ivey, Frederic J Kaye

NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

NSC30049 抑制 5-FU 耐药 CRC 实体和干细胞群体中的 Chk1 通路

Satya Narayan, Aruna S Jaiswal, Ritika Sharma, Akbar Nawab, Lizette Vila Duckworth, Brian K Law, Maria Zajac-Kaye, Thomas J George, Jay Sharma, Arun K Sharma, Robert A Hromas

Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators

癌细胞中组蛋白去乙酰化酶的过度表达受转录因子和表观遗传调节剂相互作用的控制

Hui Yang, Tal Salz, Maria Zajac-Kaye, Daiqing Liao, Suming Huang, Yi Qiu